Commission Optimistic Over EU MDR Readiness While Others See A Flawed System
Executive Summary
The European Commission is satisfied with the state of readiness of the EU MDR, but for TÜV-SÜD’s Sabina Hoekstra-van den Bosch the system is like a well-trained athlete who is prevented from competing properly.
You may also be interested in...
SMEs Buffeted About By EU MDR Delays Will Not Be Able To Financially Sustain Products
Companies are being told not to leave compliance with the EU’s MDR until the last minute. But many have no choice because of financial constraints and notified body capacity.
TEAM-NB Highlights Survey Figures Suggesting Massive 2024 Bulge In MDR Applications
Growing evidence demonstrates the one-year delay to the Medical Device Regulation, plus the expansion of the scope of products that could remain on the market beyond the MDR date of application, have simply pushed problems to 2024.
Why EU Regulations Are Changing The Face Of Innovation And May Be Unsustainable
The EU must keep its medtech regulation under review as rapidly changing technology and external market factors may be challenging the operability of some aspects of the new medtech regulations, especially for less mature businesses and SMEs. Legal medtech expert, Shuna Mason, of CMS explains why.